Nuralgan (Ibuprofen, Paracetamol)

Ibuprofen, one of the active ingredients in Nuralgan, blocks cyclo‑oxygenase enzymes (COX‑1 and COX‑2), which reduces the production of prostaglandins that mediate inflammation, pain, and fever. This inhibition lessens peripheral inflammation and provides analgesic effects.

The appropriate dose of Nuralgan is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and other medications. The prescriber will specify the exact amount and frequency that best meets the therapeutic need.

Use of Nuralgan during pregnancy should be avoided in the third trimester because ibuprofen may affect fetal cardiovascular development. In earlier trimesters, it should only be used if clearly needed and prescribed. Breastfeeding mothers should consult a physician, as both ibuprofen and paracetamol can pass into breast milk in small amounts.

To order Nuralgan, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will respond with pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Nuralgan combines ibuprofen’s anti‑inflammatory action with paracetamol’s central analgesic and antipyretic effects, offering broader pain relief and fever reduction than either agent alone. The combination can achieve effective symptom control at lower individual doses, potentially reducing the risk of side effects associated with higher doses of a single drug.

Nuralgan tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and store them out of reach of children.

Nuralgan is administered orally with a full glass of water. It may be taken with or without food, although taking it with food can help reduce stomach irritation. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding, especially in patients with a history of ulcers or who use anticoagulants; liver injury, particularly with excessive paracetamol exposure; severe allergic reactions such as anaphylaxis; and renal impairment in patients with pre‑existing kidney disease or dehydration.

Nuralgan should be avoided in individuals with known hypersensitivity to ibuprofen, paracetamol, or any excipients; those with active peptic ulcer disease; severe liver or kidney impairment; third‑trimester pregnancy; and patients taking other NSAIDs or anticoagulants without medical supervision.